In this study, we tested the antitumor activity of AG36 against three different subtype breast tumor cells namely MCF-7 (ER positive, HER2 negative), SK-BR-3 (ER negative, HER2 positive), and MDA-MB-231 (ER, PR, and HER2 negative). This evidence concerns the gene ERBB2 and breast neoplasm.